Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,151,950,504
+$424,092,525 QoQ
Shares Held
13,160,167
+32.6% QoQ
Ownership
6.07%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.1121668136886.ToString("F0")%
Shared 0.ToString("F0")%
None 1.8878331863113895.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. INSM ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
This page
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,151,950,504 | 13,160,167 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,727,857,979 | 9,927,936 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,322,150,480 | 9,180,963 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $512,585,785 | 5,093,261 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $258,957,554 | 3,394,384 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $335,275,428 | 4,856,249 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $524,980,814 | 7,191,518 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $489,443,710 | 7,305,130 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $252,821,593 | 9,318,894 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $157,789,115 | 5,091,614 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $108,700,087 | 4,304,954 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $86,157,522 | 4,083,295 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $61,158,348 | 3,587,000 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $75,292,771 | 3,768,407 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $76,408,969 | 3,547,306 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $67,609,743 | 3,428,486 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $79,076,042 | 3,364,938 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $96,572,090 | 3,545,231 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $110,217,666 | 4,002,094 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $123,385,653 | 4,335,406 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $203,336,699 | 5,969,956 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $402,427,629 | 12,088,544 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $489,238,485 | 15,222,106 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $411,279,081 | 14,933,881 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $215,862,126 | 13,466,134 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||